The Monash IVF Group Ltd (ASX: MFV) share price jumped 5% yesterday on news that that company has acquired Fertility Solutions – a Queensland-based provider of fertility services.
The Monash IVF share price opened yesterday at $1.34, but shares jumped up to $1.40 after the acquisition news was released to the ASX, a bump of 4.48% for the day.
In its ASX release, Monash stated: “Monash IVF is acquiring certain assets, liabilities and contracts of Fertility Solutions for initial cash consideration of $2.1 million on a debt free basis… the acquisition (initial purchase price and subsequent earn out payments) is expected to be funded through cash flows generated by Monash IVF Group.”
Fertility Solutions currently performs “in excess of 300 stimulated cycles per annum with revenues of circa $3 million.” This will add to Monash IVF’s $150.6 million in revenue that the company turned over in the 2018 year.
In justifying the move, Monash stated: “strategically, this acquisition expands Monash IVF’s existing Queensland presence by adding two additional clinics in the Sunshine Coast and Bundaberg – regions not currently serviced by Monash IVF. These regions are appealing due to the growing population in our target demographic.”
Monash IVF has struggled with low-cost competition over the past few years and the stock is still down significantly from the highs of $2.49 that it reached back in October 2016.
If you’re looking for a really special ASX stock, don’t miss this under-the-radar company set to profit off the coming marijuana boom.
A little-known ASX company just unlocked what some experts think could be the key to profiting off the coming marijuana boom.
And make no mistake – it is coming. To the tune of an estimated $US22 billion.
Cannabis legalisation is sweeping over North America, and full legalisation arrived in Canada in October 2018.
Here’s the best part: we think there’s one ASX stock that’s uniquely positioned to profit immensely from this explosive new industry… taking savvy investors along for what could be one heck of a ride.
AND, this is the first time The Motley Fool Australia has EVER put a BUY recommendation on a marijuana stock.
Simply click below to learn more on how you can profit from the coming cannabis boom.
Motley Fool contributor Sebastian Bowen has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.
The Motley Fool’s purpose is to help the world invest, better. Click here now for your free subscription to Take Stock, The Motley Fool’s free investing newsletter. Packed with stock ideas and investing advice, it is essential reading for anyone looking to build and grow their wealth in the years ahead. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson. 2019